ROBAPHARM AG has a total of 76 patent applications. Its first patent ever was published in 1961. It filed its patents most often in Switzerland, Romania and Bulgaria. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are CHONG KUN DANG CORP, MERZ & CO and NYEGAARD & CO AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Switzerland | 12 | |
#2 | Romania | 6 | |
#3 | Bulgaria | 5 | |
#4 | Czechoslovakia | 5 | |
#5 | Germany | 5 | |
#6 | France | 5 | |
#7 | USSR (Union of Socialist Soviet Republics) | 4 | |
#8 | Israel | 3 | |
#9 | Portugal | 3 | |
#10 | United States | 3 | |
#11 | South Africa | 3 | |
#12 | Argentina | 2 | |
#13 | Denmark | 2 | |
#14 | EPO (European Patent Office) | 2 | |
#15 | Finland | 2 | |
#16 | Hungary | 2 | |
#17 | Ireland | 2 | |
#18 | Sweden | 2 | |
#19 | Australia | 1 | |
#20 | Brazil | 1 | |
#21 | China | 1 | |
#22 | Spain | 1 | |
#23 | United Kingdom | 1 | |
#24 | Republic of Korea | 1 | |
#25 | Norway | 1 | |
#26 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Furniture and games | |
#6 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides | |
#6 | Sanitary equipment | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Pigments |
# | Name | Total Patents |
---|---|---|
#1 | Rosenberg Thea | 9 |
#2 | Baggaley Keith H | 8 |
#3 | Engel Kurt Dr | 8 |
#4 | Engel Kurt | 5 |
#5 | Baggaley | 5 |
#6 | Baggali Kit Govard | 4 |
#7 | Kurt Engel Dr | 4 |
#8 | Sorg Clemens | 4 |
#9 | Thea Rosenberg | 3 |
#10 | Thorne David E | 2 |
Publication | Filing date | Title |
---|---|---|
IE870468L | Human angiogenic factor | |
IL81650D0 | Purified human angiogenic factor,method for its preparation and pharmaceutical preparations | |
DE3626414A1 | A preparation for stimulating chondrocytes and osteoblasts (ossein-hydroxyapatite complex), process for its preparation and medicament containing the same | |
ES430638A1 | Procedure for the preparation of compounds of hypoglycemic action. (Machine-translation by Google Translate, not legally binding) | |
CH527797A | Salicylamide ether derivs - with analgesic, antipyretic and anti-inflammatory activity | |
IL32289D0 | Derivatives of benzoxazoline-2-one and a method for producing the same | |
US3528974A | Dihydro-1,3-benzoxazine-2,4-dione |